Informations sur le produit
- N2-[(2-Hydroxyethyl)-N6-benzyladenine
- 6-(Benzylamino)-2-(2-hydroxyethylamino)-9-methylpurine
- NSC 666096
- 2-(2-Hydroxyethylamino)-6-Benzylamino-9-Methylpurine
- 2-(2′-Hydroxyethylamino)-9-methyl-6-(benzylamino)purine
- 2-(6-Benzylamino-9-methyl-9H-purin-2-ylamino)-ethanol
- 2-[[6-(Benzylamino)-9-methylpurin-2-yl]amino]ethanol
- 2-[[9-Methyl-6[(Phenylmethyl)Amino]-9H-Purin-2-Yl]Amino]-Ethanol
- 2-{[6-(benzylamino)-9-methyl-9H-purin-2-yl]amino}ethanol
- 6-Benylamino-2-(2-Hydroxyethylamino)-9-Methylpurine
- Voir d'autres synonymes
- 6-Benzylamino-2-(2-Hydroxyethylamino)-9-Methylpurine
- Ethanol, 2-[[9-methyl-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-
- N2-[(2-Hydroxyethyl)]-N6-Benzyladenine
- Olomoucine Synthetic >95%
- Olomoucine,highpurity
Applications A purine derivative which inhibits cyclin-dependent kinases and induces G1 arrest.
References Vesely, J., et a.: Eur. J. Biochem., 224, 771 (1994), Abraham, R.T., et al.: Biol. Cell, 83, 105 (1995)